[English] 日本語
Yorodumi- PDB-9k6x: Structural and functional basis of antinociceptive action of cono... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9k6x | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Structural and functional basis of antinociceptive action of conotoxin AoIA at the noradrenaline transporter | ||||||||||||||||||||||||
Components |
| ||||||||||||||||||||||||
Keywords | TRANSPORT PROTEIN / Complex | ||||||||||||||||||||||||
| Function / homology | Function and homology informationneurotransmitter:sodium symporter activity / Defective SLC6A2 causes orthostatic intolerance (OI) / norepinephrine uptake / : / norepinephrine:sodium symporter activity / dopamine:sodium symporter activity / neurotransmitter transmembrane transporter activity / monoamine transmembrane transporter activity / : / SLC-mediated transport of neurotransmitters ...neurotransmitter:sodium symporter activity / Defective SLC6A2 causes orthostatic intolerance (OI) / norepinephrine uptake / : / norepinephrine:sodium symporter activity / dopamine:sodium symporter activity / neurotransmitter transmembrane transporter activity / monoamine transmembrane transporter activity / : / SLC-mediated transport of neurotransmitters / neuron cellular homeostasis / dopamine uptake involved in synaptic transmission / neuronal cell body membrane / neurotransmitter transport / amino acid transport / alpha-tubulin binding / beta-tubulin binding / sodium ion transmembrane transport / synaptic vesicle membrane / actin binding / presynaptic membrane / chemical synaptic transmission / response to xenobiotic stimulus / axon / cell surface / membrane / metal ion binding / plasma membrane Similarity search - Function | ||||||||||||||||||||||||
| Biological species | Homo sapiens (human) Conus marmoreus (invertebrata) | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.77 Å | ||||||||||||||||||||||||
Authors | Zhang, H. / Harald, S. / Oliver, B. / Xu, E.H. | ||||||||||||||||||||||||
| Funding support | China, 1items
| ||||||||||||||||||||||||
Citation | Journal: Nat Struct Mol Biol / Year: 2026Title: Structural and functional basis of antinociceptive action of χ-conotoxin AoIA at the noradrenaline transporter. Authors: Oliver J V Belleza / Heng Zhang / Helmut Schmidhammer / Tye I Gonzalez / Cosmin I Ciotu / Nataša Tomašević / Carlo Martin M Ocampo / Jomari C Fernando / Johannes Koehbach / Paula Schwarz ...Authors: Oliver J V Belleza / Heng Zhang / Helmut Schmidhammer / Tye I Gonzalez / Cosmin I Ciotu / Nataša Tomašević / Carlo Martin M Ocampo / Jomari C Fernando / Johannes Koehbach / Paula Schwarz / Mounaf Al Makhlouf / Gabor Tajti / Simon Hasinger / Nina Kastner / Orcun Avsar / Bernhard Retzl / Kathrin Jäntsch / Yi Jiang / Roland Hellinger / Michael J M Fischer / K Johan Rosengren / Christian W Gruber / Aaron Joseph L Villaraza / Thomas Stockner / Mariana Spetea / H Eric Xu / Harald H Sitte / ![]() Abstract: The χ-conotoxins are venom-derived peptides that specifically target the noradrenaline transporter (also known as norepinephrine transporter, NET). Regulation of noradrenergic signaling by NET ...The χ-conotoxins are venom-derived peptides that specifically target the noradrenaline transporter (also known as norepinephrine transporter, NET). Regulation of noradrenergic signaling by NET affects neurophysiological processes, including pain. Therefore, the χ-conotoxin MrIA and its synthetic analogs have been previously investigated for their analgesic activity. Here we describe the synthesis and pharmacological characterization of χ-AoIA, a peptide that selectively inhibits NET with a higher potency compared to MrIA in in vitro radiotracer flux assays. Furthermore, we resolved the structure of the human NET:χ-AoIA complex by cryogenic electron microscopy, which revealed an atypical binding mode consisting of both the central binding site and the outer vestibule of the transporter. Lastly, χ-AoIA displays antinociceptive efficacy in a model of inflammatory pain after subcutaneous administration in mice. Our results demonstrate the efficacy of χ-AoIA as a highly selective ligand of NET and provide a mechanistic basis for its potential development as a nonopioid analgesic. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9k6x.cif.gz | 220.1 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9k6x.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9k6x.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/k6/9k6x ftp://data.pdbj.org/pub/pdb/validation_reports/k6/9k6x | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 62139MC ![]() 9pazC ![]() 9pb0C M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Protein/peptide / Protein , 2 types, 4 molecules CDAB
| #1: Protein/peptide | Mass: 1319.643 Da / Num. of mol.: 2 / Source method: obtained synthetically / Source: (synth.) Conus marmoreus (invertebrata)#2: Protein | Mass: 70715.875 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: SLC6A2, NAT1, NET1, SLC6A5 / Production host: Homo sapiens (human) / References: UniProt: P23975 |
|---|
-Non-polymers , 4 types, 22 molecules 




| #3: Chemical | Mass: 508.582 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C24H45O9P / Feature type: SUBJECT OF INVESTIGATION #4: Chemical | ChemComp-NA / #5: Chemical | #6: Chemical | ChemComp-CLR / |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Cryo-EM structure of human norepinephrine transporter NET in an outward-open state in complex with a conotoxin ArXA-B Type: COMPLEX / Entity ID: #2, #1 / Source: RECOMBINANT |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Source (recombinant) | Organism: Homo sapiens (human) |
| Buffer solution | pH: 7.5 |
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: SPOT SCAN |
| Electron lens | Mode: DIFFRACTION / Nominal defocus max: 3000 nm / Nominal defocus min: 1000 nm / Cs: 2.7 mm |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: FEI FALCON IV (4k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Symmetry | Point symmetry: C2 (2 fold cyclic) | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.77 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 112752 / Symmetry type: POINT | ||||||||||||||||||||||||
| Refinement | Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
Conus marmoreus (invertebrata)
China, 1items
Citation




PDBj








FIELD EMISSION GUN